Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Eyenovia Inc (NQ: EYEN )

0.5300 -0.0200 (-3.64%)
Streaming Delayed Price Updated: 3:22 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eyenovia Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
EYEN Shares Are Trading Higher Today: What You Need To Know
Eyenovia shares are surging Monday in response to the company's announcement of the launch of a new FDA-approved ophthalmic drug in collaboration with Formosa Pharmaceuticals. 
Via Benzinga
Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?
Eyenovia (stock surges with high trading volume after announcing a $5.14 million offering to fund commercialization of Mydcombi, pediatric myopia research, and debt repayment. 
Via Benzinga
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
Via Benzinga
Crude Oil Down 1%; BigBear.ai Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Recap: Eyenovia Q4 Earnings
Via Benzinga
Earnings Preview For Eyenovia
Via Benzinga
Why Eyenovia (EYEN) Stock Is Getting Hammered Today
Eyenovia shares are trading lower by 35% Wednesday morning. The company announced plans to sell shares or pre-funded warrants in a best efforts offering. 
Via Benzinga
US Stocks Higher; Target Posts Upbeat Earnings
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q2 2024
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Crude Oil Moves Higher; Deere Cuts Profit Outlook
Via Benzinga
Exposures Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q1 2024
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q4 2023
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation
FDA-approved clobetasol propionate ophthalmic suspension 0.05% (APP13007) by Formosa Pharma & AimMax. Breakthrough post-ocular surgery relief, first in 15 years. Eyenovia partnership. $1.3 billion... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.